Mediwelcome: Reasonable valuation with HK listing on track for January 19 HONG KONG, Jan 6, 2021 - (ACN Newswire) - With the improvement in China's economic level, the ageing population and the unhealthy living habits of adolescents, the incidence of cardiovascular and cerebrovascular disease is increasing. There were 391 million patients with cardiovascular and cerebrovascular diseases in China in 2019, or 26.8% of the population. The incidence of cardiovascular and cerebrovascular disease in China will increase to about 429 million in 2024. In this huge market space, Mediwelcome, a Beijing-based provider of comprehensive medical marketing solutions for cardiovascular and cerebrovascular diseases, faces excellent development opportunities. Its Hong Kong shares (02159.HK) will list on January 19, so further exploration of the company's quality and reputation follows.